A study to demonstrate change in the number of C. difficilevegetative cells and spores in stool of patients with C.difficile infection (CDI) receiving fidaxomicin (FDX) or vancomycin (VAN).
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Fidaxomicin (Primary) ; Vancomycin (Primary)
- Indications Clostridium-difficile-infections
- Focus Therapeutic Use
- 18 Dec 2015 New trial record